{"disease":{"id":"late-onset-schizophrenia","name":"late onset schizophrenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06336382","title":"Tau Biomarkers in Late-onset Psychosis (LOP)","phase":"","overall_status":"RECRUITING","enrollment_count":16,"lead_sponsor_name":"Jeremy Koppel","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}